Digital physical therapy provider Hinge Health raised $437M in its US IPO, after the company and its backers sold 13.7M shares at $32 each, the top of its range
Anthony Hughes / Bloomberg :
Context & Ripple Effects
Hinge Health entered the public-markets process after reporting 2024 revenue of about $390M and a sharply narrower loss in its IPO filing, following years of private financing that included a $400M round at a $6.2B valuation.
The offering creates a public valuation and liquidity event for a virtual musculoskeletal-care provider already deployed at roughly 1,000 employers, giving the category a more visible operating benchmark.
First-order effects
- Hinge Health and its selling shareholders receive $437M in gross IPO proceeds from shares priced at the top of the range, while public investors gain a direct way to value its employer-focused virtual MSK model.
- Major private backers—including Insight, Atomico, Tiger Global, Bessemer and Coatue—now have a public-market reference point for their holdings rather than only the company’s 2021 private valuation.
Second-order effects
- Hinge’s disclosed revenue and loss trajectory will give employer buyers and rivals a clearer comparison point for virtual physical therapy economics and scale.
- Other digital MSK providers, including Sword Health, face a more concrete public-company benchmark when pursuing employer contracts or future financing.
Third-order effects
- If Hinge sustains public-market support, digital MSK care could shift from venture-funded category building toward operating performance, employer distribution and demonstrable unit economics as the principal measures of success.
- A public comparable may make the gap between scaled digital-care platforms and earlier-stage peers more consequential, though the durability of that divide will depend on Hinge’s post-IPO execution.
The trend: Digital healthcare companies that can pair sizable employer distribution with improving losses are increasingly being tested as durable public-market businesses rather than private-growth narratives.